Literature DB >> 31613865

Cardiac and Skeletal Muscle Myosin Exert Procoagulant Effects.

Julia R Coleman1, Ernest E Moore1,2, Jevgenia Zilberman-Rudenko3,4, Jason M Samuels1, Mitchell J Cohen1,2, Christopher C Silliman1,5,6, Anirban Banerjee1, Angela Sauaia1, John H Griffin3, Hiroshi Deguchi3.   

Abstract

INTRODUCTION: Trauma-induced coagulopathy (TIC) and the tissue injury-provoked procoagulant profile are prevalent in severely injured patients, but their mechanisms remain unclear. Myosin, exposed by or released from tissue injury, may play a role in promoting thrombin generation and attenuating fibrinolysis. The objective of the study is to examine the effects of cardiac and skeletal muscle myosins on coagulation in whole blood using thrombelastography (TEG).
MATERIALS AND METHODS: Whole blood was collected from healthy adult volunteers (n=8) and native TEGs were performed to evaluate the global coagulation response in the presence of cardiac or skeletal muscle myosin by measuring reaction (R) time (minutes), clot angle (), and maximum amplitude (MA, mm). TEG measurements were compared using paired t tests.
RESULTS: Cardiac and skeletal muscle myosins decreased R, from 10.8 min to 8.0 min (P<0.0001) and 6.9 min (P =0.0007), respectively. There were no effects observed on clot propagation (angle) or clot strength (MA) with myosin addition. In the presence of tPA, both cardiac and skeletal muscle myosins shortened R from 11.1 min to 8.62 min (P=0.0245) and 7.75 min (P =0.0027), respectively), with no changes on angle or MA.
CONCLUSIONS: Cardiac and skeletal muscle myosins exhibit procoagulant effects in TEG assays. These whole blood TEG results support the hypothesis that cardiac and skeletal muscle myosins may be either pro-hemostatic or prothrombotic depending on context.

Entities:  

Year:  2019        PMID: 31613865      PMCID: PMC6989346          DOI: 10.1097/SHK.0000000000001426

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  8 in total

1.  Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in Rats.

Authors:  Peter M Burch; David Greg Hall; Elizabeth G Walker; William Bracken; Richard Giovanelli; Richard Goldstein; Richard E Higgs; Nicholas M P King; Pamela Lane; John-Michael Sauer; Laura Michna; Nagaraja Muniappa; Michael L Pritt; Katerina Vlasakova; David E Watson; Debra Wescott; Tanja S Zabka; Warren E Glaab
Journal:  Toxicol Sci       Date:  2015-12-31       Impact factor: 4.849

2.  The rate of deep vein thrombosis doubles in trauma patients with hypercoagulable thromboelastography.

Authors:  Jason B Brill; Jayraan Badiee; Ashley L Zander; James D Wallace; Paul R Lewis; Michael J Sise; Vishal Bansal; Steven R Shackford
Journal:  J Trauma Acute Care Surg       Date:  2017-09       Impact factor: 3.313

3.  Response of Novel Skeletal Muscle Biomarkers in Dogs to Drug-Induced Skeletal Muscle Injury or Sustained Endurance Exercise.

Authors:  Katerina Vlasakova; Pamela Lane; Laura Michna; Nagaraja Muniappa; Frank D Sistare; Warren E Glaab
Journal:  Toxicol Sci       Date:  2017-04-01       Impact factor: 4.849

4.  Acute traumatic coagulopathy.

Authors:  Karim Brohi; Jasmin Singh; Mischa Heron; Timothy Coats
Journal:  J Trauma       Date:  2003-06

5.  Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

Authors:  Hiroshi Deguchi; Ranjeet K Sinha; Patrizia Marchese; Zaverio M Ruggeri; Jevgenia Zilberman-Rudenko; Owen J T McCarty; Mitchell J Cohen; John H Griffin
Journal:  Blood       Date:  2016-07-15       Impact factor: 22.113

6.  A New Surgical Model of Skeletal Muscle Injuries in Rats Reproduces Human Sports Lesions.

Authors:  P Contreras-Muñoz; A Fernández-Martín; R Torrella; X Serres; M De la Varga; G Viscor; T A H Järvinen; V Martínez-Ibáñez; J L Peiró; G Rodas; M Marotta
Journal:  Int J Sports Med       Date:  2015-12-15       Impact factor: 3.118

7.  Epidemiology of trauma deaths: a reassessment.

Authors:  A Sauaia; F A Moore; E E Moore; K S Moser; R Brennan; R A Read; P T Pons
Journal:  J Trauma       Date:  1995-02

8.  Fast and slow myosins as markers of muscle injury.

Authors:  M Guerrero; M Guiu-Comadevall; J A Cadefau; J Parra; R Balius; A Estruch; G Rodas; J L Bedini; R Cussó
Journal:  Br J Sports Med       Date:  2007-12-10       Impact factor: 13.800

  8 in total
  7 in total

1.  Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo.

Authors:  Jevgenia Zilberman-Rudenko; Hiroshi Deguchi; Meenal Shukla; Yoshimasa Oyama; Jennifer N Orje; Zihan Guo; Tine Wyseure; Laurent O Mosnier; Owen J T McCarty; Zaverio M Ruggeri; Tobias Eckle; John H Griffin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-02-27       Impact factor: 8.311

2.  von Willebrand factor binding to myosin assists in coagulation.

Authors:  Veronica H Flood; Tricia L Slobodianuk; Daniel Keesler; Hannah K Lohmeier; Scot Fahs; Liyun Zhang; Pippa Simpson; Robert R Montgomery
Journal:  Blood Adv       Date:  2020-01-14

3.  Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults.

Authors:  Taichi K Deguchi; Hiroshi Deguchi; Zihan Guo; Darlene J Elias; John H Griffin
Journal:  Thromb Res       Date:  2020-02-27       Impact factor: 3.944

Review 4.  Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin.

Authors:  Hiroshi Deguchi; Shravan Morla; John H Griffin
Journal:  J Thromb Haemost       Date:  2020-10-25       Impact factor: 5.824

5.  Procoagulant activities of skeletal muscle and cardiac myosins require both myosin protein and myosin-associated anionic phospholipids.

Authors:  Shravan Morla; Hiroshi Deguchi; José A Fernández; Wolfram Ruf; Rolf A Brekken; John H Griffin
Journal:  Blood       Date:  2021-04-01       Impact factor: 22.113

6.  Full-length plasma skeletal muscle myosin isoform deficiency is associated with coagulopathy in acutely injured patients.

Authors:  Julia R Coleman; Hiroshi Deguchi; Taichi K Deguchi; Mitchel J Cohen; Ernest E Moore; John H Griffin
Journal:  J Thromb Haemost       Date:  2022-03-20       Impact factor: 16.036

7.  Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity.

Authors:  Shravan Morla; Hiroshi Deguchi; John H Griffin
Journal:  J Thromb Haemost       Date:  2020-12-10       Impact factor: 5.824

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.